Thousands of <em>BRCA1</em> Genetic Variants Functionally Characterized
Thousands of BRCA1 Genetic Variants Functionally Characterized
The researchers catalogued 3,893 variants of the gene implicated in cancer using CRISPR.
Thousands of BRCA1 Genetic Variants Functionally Characterized
Thousands of BRCA1 Genetic Variants Functionally Characterized

The researchers catalogued 3,893 variants of the gene implicated in cancer using CRISPR.

The researchers catalogued 3,893 variants of the gene implicated in cancer using CRISPR.

BRCA1
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
First Direct-to-Consumer BRCA Test Authorized by FDA
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.
Genetic Risk Factors for Breast Cancer Identified
Genetic Risk Factors for Breast Cancer Identified
Ashley P. Taylor | Oct 23, 2017
Researchers identify 72 novel genetic variants associated with breast cancer risk.
Myriad, Post Mortem
Myriad, Post Mortem
The Scientist Staff | Jun 1, 2016
David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.
BRCA1 Linked to Alzheimer’s
BRCA1 Linked to Alzheimer’s
Jef Akst | Nov 30, 2015
The cancer-related protein BRCA1 is important for learning and memory in mice and is depleted in the brains of Alzheimer’s patients, according to a study.
BRCA Breakthroughs?
BRCA Breakthroughs?
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.
<em>BRCA</em> Mutations Mapped
BRCA Mutations Mapped
Tracy Vence | Apr 8, 2015
In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.
Australian Court Upholds Patents on Human Genes
Australian Court Upholds Patents on Human Genes
Molly Sharlach | Sep 8, 2014
The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.
Yet Another Lawsuit over Genetic Tests
Yet Another Lawsuit over Genetic Tests
Tracy Vence | Jun 17, 2014
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.